Perigon Wealth Management
TXG icon

Perigon Wealth Management’s 10x Genomics TXG Stock Holding History

Perigon Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$608K Sell
6,728
-643
-9% -$37.6K 0.01% 803
2026
Q2 		$283K Buy
+7,371
New +$193K ﹤0.01% 1153
2024
Q4 		– Sell
-16,537
Closed -$373K – 1101
2024
Q3 		$373K Buy
16,537
+3,784
+30% +$78.2K 0.01% 706
2024
Q2 		$248K Sell
12,753
-1,415
-10% -$37.1K 0.01% 756
2024
Q1 		$532K Buy
14,168
+4,512
+47% +$198K 0.02% 516
2023
Q4 		$540K Buy
9,656
+1,818
+23% +$79.1K 0.02% 476
2023
Q3 		$323K Sell
7,838
-2,593
-25% -$135K 0.01% 559
2023
Q2 		$582K Buy
10,431
+81
+0.8% +$4.38K 0.02% 421
2023
Q1 		$577K Buy
10,350
+140
+1% +$6.54K 0.03% 369
2022
Q4 		$372K Buy
10,210
+3,044
+42% +$100K 0.02% 464
2022
Q3 		$204K Buy
7,166
+408
+6% +$15.5K 0.02% 543
2022
Q2 		$306K Buy
6,758
+1,541
+30% +$80K 0.03% 426
2022
Q1 		$397K Buy
5,217
+1,331
+34% +$116K 0.03% 407
2021
Q4 		$579K Buy
3,886
+1,600
+70% +$245K 0.04% 310
2021
Q3 		$333K Buy
2,286
+109
+5% +$18.7K 0.03% 392
2021
Q2 		$426K Buy
2,177
+28
+1% +$5.07K 0.04% 340
2021
Q1 		$389K Buy
2,149
+670
+45% +$116K 0.04% 341
2020
Q4 		$209K Buy
+1,479
New +$215K 0.02% 385

Other funds holding TXG

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Counterpoint Mutual Funds
Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Perigon Wealth Management's TXG Position: Q3 2026 in Review

Perigon Wealth Management reduced its 10x Genomics (TXG) stake by 8.7% in Q3 2026, selling an estimated $37.6K and leaving 6,728 shares worth $608K. The position accounts for 0.01% of the portfolio, ranked #803.

Perigon Wealth Management first reported a position in TXG in Q4 2020 and has held it in 18 quarters since. 168 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Perigon Wealth Management held 6,728 shares of 10x Genomics worth $608K as of Q3 2026.
  • Perigon Wealth Management sold 643 10x Genomics shares in Q3 2026, an estimated $37.6K.
  • 10x Genomics made up 0.01% of Perigon Wealth Management's portfolio in Q3 2026, its #803 holding.
  • Perigon Wealth Management first reported a position in 10x Genomics in Q4 2020 and has held it in 18 quarters since.
  • 168 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.